Back
Cara Therapeutics Stock Price Chart
Sponsored
CARA
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
10
CARA
Cara Therapeutics
Last Price:
0.31
Seasonality Move:
-5.78%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and CARA is experiencing slight buying pressure.
Cara Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.28 | Buy |
20-day SMA: | 0.32 | Sell |
50-day SMA: | 0.34 | Sell |
200-day SMA: | 0.61 | Sell |
8-day EMA: | 0.28 | Buy |
20-day EMA: | 0.31 | Sell |
50-day EMA: | 0.35 | Sell |
200-day EMA: | 0.93 | Sell |
Cara Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 40.13 | Sell |
Chaikin Money Flow: | -15337 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.29 - 0.35) | Sell |
Bollinger Bands (100): | (0.26 - 0.64) | Sell |
Cara Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cara Therapeutics Stock
Is Cara Therapeutics Stock a Buy?
- Cara Therapeutics share price is 0.29 while CARA 8-day simple moving average is 0.28, which is a Buy signal.
- The stock price of CARA is 0.29 while Cara Therapeutics 20-day SMA is 0.32, which makes it a Sell.
- Cara Therapeutics 50-day simple moving average is 0.34 while CARA share price is 0.29, making it a Sell technically.
- CARA stock price is 0.29 and Cara Therapeutics 200-day simple moving average is 0.61, creating a Sell signal.
CARA Technical Analysis vs Fundamental Analysis
Sell
10
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy or a Sell?
-
Cara Therapeutics stock is rated a Sell
The current Cara Therapeutics [CARA] share price is $0.29. The Score for CARA is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Cara Therapeutics Stock Info
Market Cap:
15.69M
Price in USD:
0.29
Share Volume:
506.13K
Cara Therapeutics 52-Week Range
52-Week High:
1.92
52-Week Low:
0.24
Sell
10
Cara Therapeutics (CARA)
is a Sell
Cara Therapeutics Share Price Forecast
-
What is the Cara Therapeutics stock price today?
The Cara Therapeutics stock price is 0.29 USD today. -
Will CARA stock go up or go down?
Cara Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cara Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cara Therapeutics is overvalued.
Is Cara Therapeutics Stock a Buy?
- Cara Therapeutics share price is 0.29 while CARA 8-day exponential moving average is 0.28, which is a Buy signal.
- The stock price of CARA is 0.29 while Cara Therapeutics 20-day EMA is 0.31, which makes it a Sell.
- Cara Therapeutics 50-day exponential moving average is 0.35 while CARA share price is 0.29, making it a Sell technically.
- CARA stock price is 0.29 and Cara Therapeutics 200-day simple moving average is 0.93, creating a Sell signal.
Fundamental Analysis of Cara Therapeutics
Is Cara Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.52 per share.
Technical Analysis of Cara Therapeutics
Should I short Cara Therapeutics stock?
- CARA Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Cara Therapeutics is a Sell
- Cara Therapeutics Relative Strength Index (RSI) is 40.13, which suggest Cara Therapeutics is oversold
- The Bollinger Bands (25) for Cara Therapeutics is (0.29 - 0.35), which suggest Cara Therapeutics is a Sell
- The Bollinger Bands (100) for Cara Therapeutics is (0.26 - 0.64), which suggest Cara Therapeutics is a Sell
* Cara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.